View in EDS HTML Full Text PDF Full Text

Intestinal P-gp and Putative Hepatic OATP1B Induction: International Transporter Consortium Perspective on Drug Development Implications.

Saved in:
Bibliographic Details
Title: Intestinal P-gp and Putative Hepatic OATP1B Induction: International Transporter Consortium Perspective on Drug Development Implications.
Authors: Zamek-Gliszczynski MJ; Drug Meabolism and Pharmacokinetics, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Patel M; Pharmacokinetics and Drug Metabolism, Amgen Research, Cambridge, Massachusetts, USA., Yang X; Office of Clinical Pharmacology, US Food and Drug Administration, Silver Spring, Maryland, USA., Lutz JD; Department of Clinical Pharmacology, Gilead Sciences, Inc, Foster City, California, USA., Chu X; Department of Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & CO., Inc, Kenilworth, New Jersey, USA., Brouwer KLR; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Lai Y; Drug Metabolism, Gilead Sciences, Inc., Foster City, California, USA., Lee CA; Nonclinical Development and Clinical Pharmacology, Arena Pharmaceuticals, San Diego, California, USA., Neuhoff S; Simcyp Division, Certara UK Limited, Sheffield, UK., Paine MF; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, Washington, USA., Sugiyama Y; Sugiyama Laboratory, RIKEN Baton Zone, Program, RIKEN Cluster for Science, RIKEN, Yokohama, Kanagawa, Japan., Taskar KS; Drug Meabolism and Pharmacokinetics, GlaxoSmithKline, Ware, UK., Galetin A; Centre for Applied Pharmacokinetic Research, School of Health Sciences, The University of Manchester, Manchester, UK.
Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Jan; Vol. 109 (1), pp. 55-64. Date of Electronic Publication: 2020 Jul 09.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32460379
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Intestinal P-gp and Putative Hepatic OATP1B Induction: International Transporter Consortium Perspective on Drug Development Implications.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zamek-Gliszczynski+MJ%22">Zamek-Gliszczynski MJ</searchLink>; Drug Meabolism and Pharmacokinetics, GlaxoSmithKline, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Patel+M%22">Patel M</searchLink>; Pharmacokinetics and Drug Metabolism, Amgen Research, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Yang+X%22">Yang X</searchLink>; Office of Clinical Pharmacology, US Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Lutz+JD%22">Lutz JD</searchLink>; Department of Clinical Pharmacology, Gilead Sciences, Inc, Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Chu+X%22">Chu X</searchLink>; Department of Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & CO., Inc, Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Brouwer+KLR%22">Brouwer KLR</searchLink>; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Lai+Y%22">Lai Y</searchLink>; Drug Metabolism, Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Lee+CA%22">Lee CA</searchLink>; Nonclinical Development and Clinical Pharmacology, Arena Pharmaceuticals, San Diego, California, USA.<br /><searchLink fieldCode="AU" term="%22Neuhoff+S%22">Neuhoff S</searchLink>; Simcyp Division, Certara UK Limited, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Paine+MF%22">Paine MF</searchLink>; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Sugiyama+Y%22">Sugiyama Y</searchLink>; Sugiyama Laboratory, RIKEN Baton Zone, Program, RIKEN Cluster for Science, RIKEN, Yokohama, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Taskar+KS%22">Taskar KS</searchLink>; Drug Meabolism and Pharmacokinetics, GlaxoSmithKline, Ware, UK.<br /><searchLink fieldCode="AU" term="%22Galetin+A%22">Galetin A</searchLink>; Centre for Applied Pharmacokinetic Research, School of Health Sciences, The University of Manchester, Manchester, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2021 Jan; Vol. 109 (1), pp. 55-64. <i>Date of Electronic Publication: </i>2020 Jul 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32460379
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cpt.1916
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 55
    Titles:
      – TitleFull: Intestinal P-gp and Putative Hepatic OATP1B Induction: International Transporter Consortium Perspective on Drug Development Implications.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zamek-Gliszczynski MJ
      – PersonEntity:
          Name:
            NameFull: Patel M
      – PersonEntity:
          Name:
            NameFull: Yang X
      – PersonEntity:
          Name:
            NameFull: Lutz JD
      – PersonEntity:
          Name:
            NameFull: Chu X
      – PersonEntity:
          Name:
            NameFull: Brouwer KLR
      – PersonEntity:
          Name:
            NameFull: Lai Y
      – PersonEntity:
          Name:
            NameFull: Lee CA
      – PersonEntity:
          Name:
            NameFull: Neuhoff S
      – PersonEntity:
          Name:
            NameFull: Paine MF
      – PersonEntity:
          Name:
            NameFull: Sugiyama Y
      – PersonEntity:
          Name:
            NameFull: Taskar KS
      – PersonEntity:
          Name:
            NameFull: Galetin A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2021 Jan
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1532-6535
          Numbering:
            – Type: volume
              Value: 109
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical pharmacology and therapeutics
              Type: main
ResultId 1